2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin and haloperidol
2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin has been researched along with haloperidol in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Blasco-Ibáñez, JM; Castillo-Gómez, E; Crespo, C; Gómez-Climent, MA; Guirado, R; Martínez-Guijarro, FJ; Nácher, J; Varea, E | 1 |
Other Studies
1 other study(ies) available for 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin and haloperidol
Article | Year |
---|---|
Dopamine acting through D2 receptors modulates the expression of PSA-NCAM, a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats.
Topics: Analysis of Variance; Animals; Dopamine; Dopamine Agonists; Dopamine Antagonists; Glutamate Decarboxylase; Haloperidol; Immunohistochemistry; Male; Microscopy, Confocal; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Neurons; Phenethylamines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sialic Acids; Synaptic Transmission; Synaptophysin | 2008 |